Ledger.Open graph →

SEC Form D · filed December 21, 2009

EYEGATE PHARMACEUTICALS INC

Offering

$22.6M

Sold

$11.1M

Exemption

—

Industry

Biotechnology

Location

WALTHAM, MA

Type

—

People & firms on this filing (15)

Stephen From · Waltham, MAExec · Director Alain Maiore · Paris, I0Director Praveen Tyle · Waltham, MADirector Morton Goldberg · Waltham, MADirector Paul Chaney · Melville, NYDirector Thomas E. Hancock · Quincy, MADirector Michael Mullen · Kingston, MADirector Franklin Advisers, Inc · SAN MATEO, CAExec · Director Gregory E. Mcgowan · FORT LAUDERDALE, FLDirector John M. Lusk · SAN MATEO, CADirector Kent P. Strazza · SAN MATEO, CADirector Eric S. Fenster · Kensington, CADirector Marc Franzman · Milford, CTDirector J. S. Cleftie · Paris, I0Director Michael Mullen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗